The pharmaceutical industry is looking for generics with less than 20 identical ingredients/same content due to the effect of stepped drug prices.

This is because there is a large difference in drug price depending on whether there are more than 20 or less than 20 outsourced generics permitted to use bioequivalence test data. The recent increase in 1mg of generic for Livalo has the same effect.

According to the MFDS on the 1st, generics for Livalo (Pitavastatin), a hyperlipidemia drug, are increasing recently.

Livalo is a blockbuster product approved by JW Pharma in 2005. As of last year's UBIST, outpatient prescription sales amounted to ₩73.4 billion, ranking in the